U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6369163691Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With OsteoporosisCompletedNo Results AvailablePost Menopausal OsteoporosisDrug: Denosumab|Drug: Zoledronic Acidhttps://ClinicalTrials.gov/show/NCT01732770
6369263692A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic ConjunctivitisCompletedHas ResultsConjunctivitis, AllergicDrug: Alcaftadine 0.25%|Drug: Olopatadine 0.2%|Drug: dextran 70 0.1%/hydroxypropyl methylcellulose 0.3%https://ClinicalTrials.gov/show/NCT01732757
6369363693A Castor Bean Solution for Cleaning DenturesCompletedNo Results AvailableProstheses-related InfectionsOther: Physiological solution|Other: Sodium hypochlorite|Other: Alkaline Peroxide|Other: Castor bean solutionhttps://ClinicalTrials.gov/show/NCT01732744
6369463694Effects of Intensive Locomotor Treadmill Training on Gross Motor Function in Young Children With Neuromotor ImpairmentCompletedNo Results AvailableCerebral PalsyOther: treadmill traininghttps://ClinicalTrials.gov/show/NCT01732731
6369563695Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell DiseaseEnrolling by invitationNo Results AvailableSickle Cell Disease|Sickle Cell NephropathyDrug: Atorvastatin|Drug: Placebo for atorvastatinhttps://ClinicalTrials.gov/show/NCT01732718
6369663696High Intensity Interval Training (HIT) in Patients With Type 2 DiabetesCompletedNo Results AvailableType 2 DiabetesBehavioral: High intensity interval traininghttps://ClinicalTrials.gov/show/NCT01732705
6369763697Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel PreparationCompletedHas ResultsBowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel.Drug: MOVIPREPhttps://ClinicalTrials.gov/show/NCT01732692
6369863698Sunnaas International Network´s Stroke StudyActive, not recruitingNo Results AvailableCerebral StrokeOther: rehabilitationhttps://ClinicalTrials.gov/show/NCT01732679
6369963699Effect of Nefopam on Remifentanil Induced Postoperative HyperalgesiaCompletedNo Results AvailablePatients Undergoing Laparoscopic GastrectomyDrug: Nefopam|Drug: low dose remifentanil|Drug: high dose remifentanilhttps://ClinicalTrials.gov/show/NCT01732666
6370063700A Treadmill Training Program Augmented by Virtual Reality to Decrease Fall Risk in Older AdultsNot yet recruitingNo Results AvailableElderly Adults|Parkinson|Mild Cognitive DisorderOther: TT+VR|Other: TT alonehttps://ClinicalTrials.gov/show/NCT01732653
6370163701A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.Active, not recruitingNo Results AvailableSquamous Cell Carcinoma of the Head and NeckDrug: Afatinib|Drug: Paclitaxel|Drug: Carboplatin|Drug: Cisplatin|Radiation: Intensity Modulated Radiation Therapyhttps://ClinicalTrials.gov/show/NCT01732640
6370263702Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and OlderCompletedNo Results AvailableMeningitis|Meningococcal Meningitis|Meningococcal Infections|Invasive Meningococcal DiseaseBiological: MenACYW Conjugate Vaccine|Biological: Meningococcal Polysaccharide Vaccine Groups A, C, Y, W 135 Combinedhttps://ClinicalTrials.gov/show/NCT01732627
6370363703Topcon Endpoint ManagementCompletedNo Results AvailableDiabetic Macular EdemaProcedure: Topcon Endpoint Management laserhttps://ClinicalTrials.gov/show/NCT01732614
6370463704Intensive Outpatient Services for TeensRecruitingNo Results AvailableDepression|SuicideBehavioral: Intensive Outpatient CBT|Behavioral: Standard Carehttps://ClinicalTrials.gov/show/NCT01732601
6370563705A Comparison of the Bioavailability of OZ439 When Delivered Directly to the Small Intestine, or Via the Oral RouteCompletedHas ResultsHealthy VolunteersDrug: OZ439 120mg PIB|Drug: 120 mg OZ439 caplet|Drug: 120mg OZ439 caplet via Enterion capsulehttps://ClinicalTrials.gov/show/NCT01732588
6370663706Enrichment of Day Centers in Community-based PsychiatryCompletedNo Results AvailableEnrichment With Meaning-generating Activities|Rehabilitation as UsualBehavioral: Enrichment with meaning-generating activitieshttps://ClinicalTrials.gov/show/NCT01732575
6370763707A Trial to Establish Realistic Patient Expectations of Total Knee ReplacementRecruitingNo Results AvailableOsteoarthritisOther: Patient e-Learning educational toolhttps://ClinicalTrials.gov/show/NCT01732562
6370863708A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based ChemotherapyTerminatedNo Results AvailableMetastatic Castrate Resistant Prostate CancerDrug: Tasquinimod|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01732549
6370963709Safety and Efficacy of Bioabsorbable Drug-Eluting Sinus Implant for Chronic SinusitisCompletedNo Results AvailableChronic SinusitisDrug: S8 sinus implant|Drug: continued nasal steroid sprayhttps://ClinicalTrials.gov/show/NCT01732536
6371063710Predictive Value of Neovascularization Within Asymptomatic Carotis Stenosis on CEUSRecruitingNo Results AvailableCarotid Stenosishttps://ClinicalTrials.gov/show/NCT01732523
6371163711A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003)TerminatedNo Results AvailableAtopic DermatitisDrug: MK-8226|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01732510
6371263712Axillary Hair Reduction StudyCompletedNo Results AvailableAxillary HairDevice: miraDry Treatmenthttps://ClinicalTrials.gov/show/NCT01732497
6371363713Posterior Capsule Opacification and Frequency of Nd:YAG Treatment and of Two Microincision IOLs: Hoya iMics NY-60 vs Acrysof SN60WFCompletedHas ResultsCapsule Opacification|Pseudophakia|CataractProcedure: intraocular lens implantationhttps://ClinicalTrials.gov/show/NCT01732484
6371463714Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With PhenylketonuriaCompletedHas ResultsPhenylketonuriaDrug: Kuvan®https://ClinicalTrials.gov/show/NCT01732471
6371563715A Study to Evaluate Aprepitant for the Prevention of Post Operative Nausea and Vomiting in Children (MK-0869-219)RecruitingNo Results AvailablePost-Operative Nausea|Post-Operative VomitingDrug: Aprepitant|Drug: Placebo to match aprepitant|Drug: Ondansetron|Drug: Placebo to match ondansetronhttps://ClinicalTrials.gov/show/NCT01732458
6371663716Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With MyelofibrosisSuspendedNo Results AvailableAnemia|Primary Myelofibrosis|Secondary MyelofibrosisDrug: ruxolitinib phosphate|Drug: danazol|Other: quality-of-life assessment|Other: questionnaire administrationhttps://ClinicalTrials.gov/show/NCT01732445
6371763717Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)WithdrawnNo Results AvailableEndometrioid Carcinoma|Clear Cell Carcinoma|Endometriosishttps://ClinicalTrials.gov/show/NCT01732432
6371863718Homebased Training With Telemonitoring Guidance in Low to Moderate Risk Patients Entering Cardiac RehabilitationActive, not recruitingNo Results AvailableAcute Coronary Syndrome|Myocardial InfarctionBehavioral: Home-based training|Behavioral: Centre-based traininghttps://ClinicalTrials.gov/show/NCT01732419
6371963719Acromegaly Treatment Quality of Life StudyRecruitingNo Results AvailableAcromegalyhttps://ClinicalTrials.gov/show/NCT01732406
6372063720Effect of Quercetin in Prevention and Treatment of Oral MucositisCompletedNo Results AvailableChemotherapy Induced Oral MucositisDrug: oral quercetin capsules|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01732393

* Görseller ve İçerik tekif hakkına sahip olabilir